BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement

BullFrog AI (NASDAQ: BFRG) regained compliance with Nasdaq Listing Rule 5550(b)(1) by restoring minimum stockholders’ equity of $2,500,000 as of April 21, 2026.

Rhea-AI Summary

BullFrog AI (NASDAQ: BFRG) regained compliance with Nasdaq Listing Rule 5550(b)(1) by restoring minimum stockholders’ equity of $2,500,000 as of April 21, 2026. Compliance was achieved through sales under its at-the-market facility and an equity line of credit, extending cash runway into late 2027.

The company will be subject to a mandatory Nasdaq panel monitor for one year beginning April 21, 2026; a repeat noncompliance during that period could lead to prompt delisting procedures but allows a hearing request.

Positive

• Regained Nasdaq compliance as of April 21, 2026
• Cash runway extended into late 2027 via financing
• Commercial agreement with a top 5 global pharmaceutical company (March)

Negative

• One-year Nasdaq panel monitor starting April 21, 2026
• No extra cure period if out of compliance during the monitoring year

Argus Apr 22 session

-6.50% close to close Open Argus

Details

News Market Reaction – BFRG

In the Apr 22 session, BFRG declined 6.50%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -6.5% in the session following this news. A negative reaction despite restored compl...

Analysis

The stock moved -6.5% in the session following this news. A negative reaction despite restored compliance with Nasdaq’s $2,500,000 equity requirement fits a pattern where several positive AI updates produced near-term downside. Investors may have focused on prior reliance on at-the-market and equity-line facilities or lingering listing risk given Nasdaq’s one-year monitoring period. Historically, AI-tag news averaged 23.58% moves, so a sharp decline could reflect profit-taking or skepticism about the durability of the extended runway into late 2027.

Key Figures

Nasdaq equity requirement: $2,500,000 Panel monitor period: 1 year Cash runway: Late 2027 +5 more

Nasdaq equity requirement

$2,500,000

Minimum stockholders’ equity under Nasdaq Listing Rule 5550(b)(1)

Panel monitor period

1 year

Mandatory Nasdaq panel monitoring starting April 21, 2026

Cash runway

Late 2027

Company states balance sheet provides capital runway into late 2027

Top pharma ranking

Top 5

Commercial agreement with a top 5 global pharmaceutical company

Price change

-5.78%

24-hour move prior to this news

52-week high distance

-54.24%

Price vs 52-week high before this news

52-week low distance

119.6%

Price vs 52-week low before this news

Market cap

$18,303,218

Market capitalization prior to the announcement

Previous AI Reports

5 past events · Latest: Apr 14

Same Type 5 events

1. Apr 14

   Conference participation

   24h Move

   -3.8%

   AACR 2026 participation to showcase AI-driven drug discovery workflow.

2. Apr 13

   Business update

   24h Move

   +18.6%

   Business update on strengthened balance sheet and extended runway to late 2027.

3. Mar 30

   Commercial agreement

   24h Move

   +106.6%

   Commercial agreement with top‑5 pharma using bfLEAP in major depressive disorder.

4. Mar 25

   Platform expansion

   24h Move

   -1.6%

   Launch of bfARENAS™ decision engine to enhance AI workflow strategy.

5. Mar 11

   Webinar announcement

   24h Move

   -1.8%

   Webinar scheduled to introduce new precision AI decision-support capability.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

stockholders’ equity, at-the-market sales facility, equity-line-of-credit facility, nasdaq hearings panel

4 terms

stockholders’ equity financial

"its stockholders’ equity was below $2,500,000, which is required under Nasdaq Listing Rule 5550(b)(1)"

Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.

at-the-market sales facility financial

"As a result of sales under the Company’s existing at-the-market sales facility and equity-line-of-credit facility"

An at-the-market sales facility is an arrangement that lets a company sell newly issued shares directly into the open market at current trading prices over time through a broker, rather than in a single big offering. For investors it matters because it provides the company flexible, on-demand access to cash but can gradually reduce each existing share’s ownership and put downward pressure on the stock if many shares are sold, similar to slowly adding water to an already full cup.

equity-line-of-credit facility financial

"sales under the Company’s existing at-the-market sales facility and equity-line-of-credit facility"

A equity-line-of-credit facility is an agreement that lets a company draw cash over time by issuing new shares up to a set limit, much like tapping a tap that releases water in measured amounts instead of taking one big loan. It matters to investors because it provides flexible funding to pay bills or grow the business but can dilute existing owners’ stakes and affect the share price each time new stock is issued.

nasdaq hearings panel regulatory

"the Company will have an opportunity to request a new hearing with the Nasdaq Hearings Panel"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Strengthened balance sheet provides capital runway into late 2027

GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, today announced that it has received a written notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Rule”). On April 21, 2026, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with the Stockholders’ Equity Rule, which requires listed companies to maintain stockholders’ equity of at least $2,500,000. As a result of sales under the Company’s existing at-the-market sales facility and equity-line-of-credit facility, the Company regained compliance with the Stockholders’ Equity Rule as of April 21, 2026. The letter also stated that the Company will be subject to a mandatory panel monitor for a period of one year commencing on April 21, 2026. If, within the one-year monitoring period, the Nasdaq Listing Qualifications Staff finds the Company out of compliance with the Stockholders’ Equity Rule, the Company will not be permitted additional time to regain compliance. However, the Company will have an opportunity to request a new hearing with the Nasdaq Hearings Panel prior to the Company’s securities being delisted from Nasdaq.

“Today’s announcement is a result of executing important business objectives, on plan, in the first quarter,” said BullFrog AI’s Founder and CEO Vin Singh. “First and foremost, our commercial agreement announced in March with a top 5 global pharmaceutical company serves as high-profile third-party validation of the capabilities embedded within BullFrog AI’s proprietary technology. Second, with that pivotal commercial validation in hand, we were able to extend our cash runway by over a year, prioritizing investor friendly, minimally dilutive financing structures that preserve value. Maintaining our Nasdaq listing as a result of organic business wins and a solid balance sheet is integral to our commitment to create value for our shareholders,” concluded Mr. Singh.

About BullFrog AI

BullFrog AI leverages artificial intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP^® platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials. For more information visit BullFrog AI at: https://bullfrogai.com.

Safe Harbor Statement

This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “could,” “will,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our and our partners’ ability to market and sell our offerings and services, including BullFrog Data Networks™; our ability to maintain compliance with Nasdaq listing rules; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Contact:

Investors:
CORE IR
ir@bullfrogai.com

Media:
CORE PR
pr@bullfrogai.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did BullFrog AI (BFRG) regain Nasdaq compliance on April 21, 2026?

BullFrog AI restored required equity levels through equity sales and an equity-line draw. According to the company, sales under its at-the-market facility and an equity-line-of-credit brought stockholders’ equity to satisfy the $2,500,000 Nasdaq minimum by April 21, 2026.

What does the one-year Nasdaq panel monitor mean for BFRG shareholders?

The monitor subjects the company to closer Nasdaq oversight for one year starting April 21, 2026. According to the company, failure to remain compliant during that year could lead to delisting steps without additional cure time, though a hearing request is available.

How long is BullFrog AI’s cash runway after the April 2026 financing actions?

BullFrog AI says its strengthened balance sheet provides capital runway into late 2027. According to the company, the at-the-market sales and equity-line financing extended liquidity by over one year from current levels.

What is the significance of BullFrog AI’s March commercial agreement for BFRG investors?

The March commercial agreement is presented as third-party validation of the company’s technology by a top 5 pharma. According to the company, that contract bolsters commercial credibility and supports the execution that helped restore Nasdaq compliance.

Could BullFrog AI (BFRG) be delisted despite regaining compliance on April 21, 2026?

Delisting remains possible if the company falls out of compliance during the one-year monitoring period and Nasdaq finds noncompliance. According to the company, it would have the opportunity to request a hearing before any delisting action is finalized.